Last updated on October 2015

Clinical trial for Patients with leukemia or lymphoma MI-CP204 (The Blood Cancer Study)


Brief description of study

Clinical trial for Patients with leukemia or lymphoma MI-CP204 (The Blood Cancer Study)

Detailed Study Description

This clinical trial is provided by TrialReach.

If you have a B-cell malignancy (leukemia or lymphoma) you may be eligible to take part in this clinical research study. We are looking for people with leukemia or lymphoma that has returned after initial successful treatment (relapsed) or hasn’t improved with treatment (refractory). It can be difficult for patients with refractory or relapsed B-cell malignancies to find treatments that work well for them, which is why we need to research potential new medications.

Clinical Study Identifier: TX6637

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Molly McCormick

Mercy Cancer Center at St. Anne
Toledo, OH USA
  Connect »

Annie Fors

University of Kansas Clinical Research Center
Kansas City, KS USA
  Connect »

Christine Capper

Penn State Hershey Cancer Center
Hershey, PA USA
  Connect »

Noah Kornblum

Montefiore Medical Center
Bronx, NY USA
  Connect »

Jose Lopez

Moores UCSD Cancer Centre
La Jolla,, CA USA
  Connect »

Kristianna Maier

Mayo Clinic
Rochester, MN USA
  Connect »

Jessica Guhl

Medical College of Wisconsin Cancer Center Clinical Trials Office
Milwaukee, WI USA
  Connect »

Kelley Aldrich

Saint Luke's Hospital of Kansas City
Kansas City, MO USA
  Connect »

Ronda Carlisle

University of Alabama at Birmingham Comprehensive Cancer Care
Birmingham, AL USA
  Connect »